Home Coronavirus Dr. Fauci’s NIAID has Deep Financial and Personnel Ties to the Wuhan Institute of Virology

Dr. Fauci’s NIAID has Deep Financial and Personnel Ties to the Wuhan Institute of Virology

by Paul Ebeling

#Fauci #China #Wuhan #COVID19 #virus #deadly

Right in the wake of the release of thousands of Dr. Anthony Fauci’s e-Mails which point toward a lab creation of COVID-19, a CSPAN video from 2016 has surfaced, featuring the President of EcoHealth Alliance, a company that received millions of dollars from Dr. Fauci’s agency to turn viruses into killers.

In the video, Peter Daszak explains how his organization experiments with deadly viruses, and describes how his “colleagues in China” insert spike proteins into viruses. “You create pseudo particles, you insert the spike proteins from those viruses, see if they bind to human cells,” Mr. Daszak says in the video.

At each step of this you move closer and closer to this virus could really become pathogenic in people.”

EcoHealth Alliance “was one of the primary proxies funneling the money to the Chinese Communist Party lab” in Wuhan, China, according to The National Pulse.
Over a dozen research papers carried out under a $3.7-M National Institute of Allergy and Infectious Disease (NIAID) grant list the Wuhan Lab’s Center for Emerging Infectious Diseases Director Shi Zhengli as a co-author alongside Daszak. Shi has included these Fauci-backed grants on her resume.”

The Wuhan lab lists the National Institutes of Health (NIH) as one of its “partners,” and secretly erased the mention in March 2021.

Have a healthy day, Keep the Faith!

You may also like


Your Trusted Source for Capital Markets & Related News

© 2024 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.